Bio-Rad Laboratories Inc.

NYSE: BIO · Real-Time Price · USD
285.79
-1.42 (-0.49%)
At close: Aug 15, 2025, 3:59 PM
285.66
-0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT

Bio-Rad Laboratories Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-1.84B -637.3M -3.63B 4.25B
Depreciation & Amortization
151.6M 145.9M 137.3M 137.6M
Stock-Based Compensation
62.3M 61.3M 60.9M 51.2M
Other Working Capital
-604.6M -346.1M -1.27B 1.05B
Other Non-Cash Items
2.71B 1.24B 5.23B -4.92B
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-620.8M -432.8M -1.61B 1.14B
Operating Cash Flow
455.2M 374.94M 194.45M 669.46M
Capital Expenditures
-189M -156.68M -114.16M -133.75M
Cash Acquisitions
n/a 2.5M -99.39M -125.52M
Purchase of Investments
-1.28B -689.04M -2.06B -851.63M
Sales Maturities Of Investments
1.31B 863.22M 1.07B 766.9M
Other Investing Acitivies
-23.3M 211K -1.21M -453.39M
Investing Cash Flow
-160.2M 20.21M -1.21B -797.38M
Debt Repayment
-400K -467K 1.19B -3.02M
Common Stock Repurchased
-203.6M -428.73M -215.68M -50M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-14.8M 3.55M 3.54M -2.41M
Financial Cash Flow
-218.8M -425.65M 973.58M -55.43M
Net Cash Flow
85.4M -30.18M -36.59M -195.98M
Free Cash Flow
266.2M 218.26M 80.29M 535.72M